CVS HEALTH CORPORATION REPORTS STRONG FIRST QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

First quarter total revenues increased to $100.4 billion, up 6.2% year-over-year First quarter GAAP diluted EPS of $2.30 and Adjusted EPS of $2.57 Raising full-year 2026 guidance: GAAP diluted EPS guidance range to $6.24 to $6.44 from $5.94 to $6.14 Adjusted EPS guidance range to $7.30 to $7.50 from $7.00 to $7.20 Cash flow from operations guidance to at least $9.5 billion from at least $9.0 billion WOONSOCKET, R.I., May 6, 2026 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended March 31, 2026.